Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review
{{output}}
Introduction: Immunotherapies, including checkpoint inhibitors (CIs) such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) inhibitors, are revolutionizing the treatment of advanced melanoma. Combining CT... ...
